Mylan CEO Answers to Congress on EpiPen Pricing

Sep 15, 2016

Mylan’s CEO Heather Bresch will appear before the U.S. House Committee on Oversight and Government Reform on Sept. 21, 2016, where she will be questioned about how the company raised the price of the EpiPen to $600 for a two-pack, from $57 a shot when it took over sales of the product in 2007, according to Bloomberg.

“There is justified outrage from families and schools across the country struggling to afford the high cost of EpiPens,” said committee chairman Jason Chaffetz, a Republican from Utah.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments